Pharmaceuticals, Biotechnology and Life Sciences
PETACH TIKVA, Israel–(BUSINESS WIRE)–Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule…
First-ever Results to be Presented from Multiple Studies Evaluating Company’s PNK Allogeneic Cell Therapy in Patients with Acute Myeloid Leukemia…
TORONTO–(BUSINESS WIRE)–Northern Biologics Inc., a company focused on developing first-in-class immuno-oncology products, today announced the presentation of initial results from…
Data to be Presented at AACR Annual Meeting PRINCETON, N.J.–(BUSINESS WIRE)–Advaxis, Inc. (NASDAQ: ADXS), a late-stage biotechnology company focused on the…
BRISBANE, Calif. & ST. LOUIS–(BUSINESS WIRE)–Arch Oncology, Inc., a clinical-stage immuno-oncology company focused on the discovery and development of best-in-class…
NEW YORK–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) today issued the following statement regarding Celgene’s (NASDAQ:CELG) settlement with Lotus Pharmaceutical Co., Ltd.…
Enhanced Market Penetration of Core Marketed Products Pipeline Products Witnessed a Steady Progress to Launch Commencement of CMO Service to…
Alvogen licensed to sell volume-limited amounts of generic lenalidomide in the U.S. beginning on a confidential date after the March…
DUBLIN–(BUSINESS WIRE)–The “Global Anticoagulants Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts,…
Bristol-Myers Squibb Urges Shareholders to Vote “FOR” the Merger-Related Proposals on the WHITE Proxy Card Today NEW YORK–(BUSINESS WIRE)–Bristol-Myers Squibb…